Results 201 to 210 of about 284,151 (314)

Do patients with metastatic pancreatic adenocarcinoma to the lung have improved survival? [PDF]

Cancer Med, 2023
Ebrahimi A, Cham J, Puglisi L, De Shadarevian M, Hermel DJ, Spierling Bagsic SR, Sigal D.   +6 more
europepmc   +1 more source

Comparative Analysis of Clinical Outcomes and Financial Aspects of Phototherapies and Immunotherapy for Cancer

Advanced Science, EarlyView.
This review compares clinical outcomes, translational progress, and global funding trends across cancer phototherapies—photodynamic, photothermal, and photoimmunotherapy—and conventional immunotherapy. It highlights differences in treatment efficacy, clinical trial status, financial investment, and regulatory challenges, providing a comprehensive ...
Deepak S. Chauhan, Kun Shao, Roopa Hebbandi Nanjundappa, Daniel‐Jiajun Yu, Marianne Stanford, Huile Gao, Channakeshava Sokke Umeshappa   +6 more
wiley   +1 more source

Young-Onset, ROS1-Rearranged Adenocarcinoma of the Lung With Cardiac Tamponade: A Case Report. [PDF]

Cureus
Nojiri M, Abe R, Nagae S, Tanaka T, Takahara Y.   +4 more
europepmc   +1 more source

Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case Report. [PDF]

JTO Clin Res Rep, 2023
Sposito M, Scaglione IM, Eccher S, Pasqualin L, Avancini A, Colato C, Rosina P, Simbolo M, Caliò A, Scarpa A, Milella M, Pilotto S, Belluomini L.   +12 more
europepmc   +1 more source

Activity of growth factors in the IL-6 group in the differentiation of human lung adenocarcinoma [PDF]

, 2000
Carol McCormick, R. Ian Freshney
openalex   +1 more source

Lung adenocarcinoma

, 2017
openaire   +1 more source

Targeting Intratumoral Copper Inhibits Tumor Progression via p62‐Mediated EZH2 Degradation and Potentiates Anti‐PD‐1 Immunotherapy in Oral Squamous Cell Carcinoma

Advanced Science, EarlyView.
The authors find that by targeting intratumoral copper, they can enhance p62‐mediated ubiquitination of EZH2 at the Ub‐K63 site by suppressing copper binding to SMURF2, an E3 ligase of EZH2, leading to its autophagic degradation. This mechanism suppressed OSCC progression and potentiated anti‐PD‐1 immunotherapy, highlighting a potential new therapeutic
Xiaohu Lin, Wanling Chen, Bo Li, Zhang Zhao, Zhonglin Yu, Xu‐Yun Zhao, Xuan Zhou, Zhien Feng, Chengzhong Lin, Wei Cao   +9 more
wiley   +1 more source

Pulmonary Mycobacterium avium Complex With Adenocarcinoma of the Lung: A Case Report. [PDF]

Cureus
Mishra P, Kondisetti M, Patil A, Sarangdhar N.   +3 more
europepmc   +1 more source

Venous Gangrene in a Patient with Adenocarcinoma of the Lung [PDF]

, 2000
Mu Yang
openalex   +1 more source

Carrier‐Free Nanocapsule with Dual‐Target Capacity for Synergistically Restoring Inflammatory Microenvironment and Microbiota Dysbiosis in Colitis

Advanced Science, EarlyView.
This manuscript presents a carrier‐free nanomedicine PCNPs@PEG‐Man with dual‐targeting for IBD. It resists harsh intestinal conditions, reduces oxidative stress, enhances drug uptake and retention, modulates inflammation, and reshapes gut microbiota, offering a safe and effective IBD therapy.
Yingjie Chen, Yuhan Gao, Kaiyuan Huo, Zhaofan Jin, Wenchao Wang, Xingjie Zan, Yanlong Liu, Limeng Zhu, Jianfeng Yang   +8 more
wiley   +1 more source